Understanding Hematoma Expansion Across Hemorrhage Subtypes

Spontaneous intracerebral hemorrhage represents a devastating subtype of acute stroke. Clinicians frequently encounter hematoma expansion during the hyperacute phase, which substantially increases morbidity and mortality. Overall, hematoma expansion occurs in nearly one out of four patients regardless of anatomical location. However, emerging neurocritical research demonstrates that distinct anatomical pathways drive unique expansion patterns. A comprehensive study from Tongji Hospital evaluated 558 supratentorial hemorrhage cases, comparing deep and lobar cohorts. Although both groups demonstrated comparable overall rates of expansion at approximately twenty-three percent, their independent risk drivers diverged substantially. Deep hemorrhages, typically arising from hypertensive vasculopathy in penetrating vessels, exhibited specific radiographic and clinical vulnerabilities. Conversely, lobar hemorrhages, frequently associated with cerebral amyloid angiopathy, responded to distinct morphological and hematologic variables. Consequently, clinicians cannot rely on a single universal predictive scoring model for all presentations. Recognizing these location-specific trajectories empowers emergency teams and neurologists to tailor acute monitoring protocols. Early risk stratification therefore provides a crucial window to deliver targeted therapies and optimize neurocritical intensive care resources.

Deep Intracerebral Hemorrhage and Fluid-Level Dynamics

In deep intracerebral hemorrhage, the presence of an intrahematoma fluid level on noncontrast computed tomography serves as a powerful predictor of hematoma expansion. The Tongji cohort revealed that a fluid level increased the odds of subsequent expansion by nearly fivefold. Radiologically, a fluid level represents a horizontal interface between settled cellular elements and non-clotted serum. This radiological marker directly indicates active, continuous microvascular bleeding and defective local clot retraction within deep subcortical structures. Because deep brain regions possess dense vascular networks under high hydrostatic pressure, incomplete hemostasis permits rapid blood extravasation. Therefore, detecting this sign on initial noncontrast neuroimaging should immediately alert acute care teams. Clinicians must treat patients exhibiting fluid levels as clinically unstable candidates requiring aggressive blood pressure control. Furthermore, neurocritical pathways should prioritize continuous arterial pressure monitoring and expedited follow-up neuroimaging within twenty-four hours. By recognizing the clinical significance of intrahematoma fluid levels, acute stroke teams can intervene swiftly before extensive secondary tissue injury occurs.

Lobar Bleeds and the Role of Irregular Shape

While fluid levels dominate deep bleeds, morphological irregularity represents the chief radiological driver of hematoma expansion in lobar hemorrhages. Investigators found that an irregular hematoma contour increased expansion odds almost fivefold in lobar locations. Cortical and subcortical lobar hemorrhages frequently arise from cerebral amyloid angiopathy or fragile superficial arterioles. In these peripheral brain regions, the less constrained parenchymal architecture permits multifocal bleeding points along branching vessel networks. Consequently, multiple microhemorrhages coalesce to produce jagged, island-like, or lobulated margins on noncontrast computed tomography. This distinct morphological irregularity signals multifocal vascular fragility rather than a single focal vascular rupture. Clinicians observing irregular margins must anticipate unpredictable peripheral expansion patterns. Furthermore, surrounding lobar tissue planes offer minimal anatomical resistance to bleeding. Medical teams must therefore intensify neurological surveillance in lobar stroke cases presenting with jagged borders. Recognizing irregular hematoma contours on noncontrast scans allows clinicians to identify vulnerable patients who require prioritized neurocritical care and surgical evaluation.

Systemic Coagulation and Fibrinogen Depletion in Lobar Bleeds

Laboratory biomarkers provide crucial prognostic insights that complement neuroimaging findings in acute intracerebral hemorrhage. In lobar bleeding, baseline plasma fibrinogen levels strongly correlate with hematoma expansion risk. Specifically, research demonstrates that higher fibrinogen levels exert a substantial protective effect, reducing expansion odds by fifty-eight percent per unit increase. Fibrinogen serves as the essential substrate for stable fibrin mesh formation during hemostasis. In lobar hemorrhages, where vessel rupture frequently involves amyloid-laden cortical vessels, robust clot formation is vital to arrest microvascular leakage. Lower systemic fibrinogen concentrations impair local hemostatic plug maturation, thereby permitting prolonged microvascular oozing into lobar tissues. Consequently, patients with depleted fibrinogen levels face heightened vulnerability to continuous hematoma enlargement. Emergency clinicians must obtain rapid coagulation profiles, including quantitative fibrinogen assays, upon initial hospital presentation. Furthermore, these findings stimulate important considerations regarding targeted hemostatic therapies in selected coagulopathic cohorts. Maintaining adequate plasma fibrinogen substrate levels represents a promising target for optimizing acute stroke management.

Clinical Window and Admission Neurological Assessment

Clinical presentation metrics interact dynamically with neuroimaging markers to dictate the probability of hematoma expansion. In deep hemorrhages, both the time from symptom onset to baseline imaging and initial Glasgow Coma Scale scores independently predict expansion. Specifically, a shorter interval between symptom onset and noncontrast computed tomography significantly increases the likelihood of capturing ongoing hematoma growth. Patients presenting ultra-early arrive during the dynamic active bleeding phase before physiological tamponade occurs. Therefore, hyperacute scans often capture an expanding lesion in its early trajectory. Conversely, lower admission Glasgow Coma Scale scores reflect severe initial parenchymal disruption and mass effect. Depressed consciousness at arrival indicates larger initial volume accumulation and higher intracranial pressure. Clinical teams must remain exceptionally vigilant when evaluating comatose or stuporous patients who present shortly after symptom onset. These ultra-early arrivals require expedited neurocritical protocols and scheduled repeat neuroimaging. Recognizing the urgency of the hyperacute window allows clinicians to anticipate neurological deterioration and implement rapid stabilization.

Translating Predictive Biomarkers into Acute Stroke Protocols

Differentiating risk factors based on hemorrhage location provides a practical framework for refining acute stroke protocols. Clinicians in Indian emergency departments and intensive care units regularly manage hypertensive and amyloid-related hemorrhages under intense time constraints. Utilizing a location-based approach enhances diagnostic precision without requiring expensive ancillary imaging modalities. For deep hemorrhages, emergency physicians must prioritize rapid blood pressure titration when noncontrast scans reveal fluid levels or when patients present ultra-early. For lobar hemorrhages, teams should carefully inspect hematoma margins and order immediate fibrinogen testing. Furthermore, incorporating these distinctive clinical and imaging markers into tailored risk prediction tools improves patient stratification. Standard universal prediction scores often overlook these anatomical nuances, leading to inaccurate risk estimation. By adopting differentiated monitoring pathways, tertiary hospitals can allocate high-dependency beds and intensive monitoring resources more effectively. Ultimately, precision risk assessment bridges acute neuroimaging and bedside clinical management, optimizing functional outcomes for stroke patients.

Frequently Asked Questions

How does hematoma expansion differ between deep and lobar brain hemorrhages?

While overall expansion rates remain similar between locations at roughly twenty-three percent, the underlying risk drivers differ significantly. Deep hemorrhages expand primarily due to fluid-level dynamics, depressed consciousness, and ultra-early presentation. In contrast, lobar hemorrhages expand predominantly because of irregular morphological contours and lower baseline systemic fibrinogen concentrations.

Why is an intrahematoma fluid level significant in deep intracerebral hemorrhage?

An intrahematoma fluid level on noncontrast computed tomography indicates active ongoing bleeding and incomplete local clot retraction under high hydrostatic pressure. In deep structures like the basal ganglia, this radiological sign increases the odds of subsequent hematoma enlargement nearly fivefold, warranting intensive blood pressure control and close neurocritical monitoring.

What role does plasma fibrinogen play in lobar intracerebral hemorrhage progression?

Plasma fibrinogen provides the critical substrate required to form stable fibrin clots within fragile, amyloid-damaged cortical vessels. Lower systemic fibrinogen levels impair hemostatic plug maturation, substantially increasing expansion risk. Conversely, higher baseline fibrinogen concentrations significantly reduce expansion odds, highlighting fibrinogen measurement as an essential prognostic step in lobar bleeds.

Disclaimer: This content is for informational and educational purposes only and does not constitute formal medical advice. Healthcare professionals should exercise independent clinical judgment and correlate these findings with individualized patient assessments. Refer to the latest local and national guidelines for clinical practice.

References

1. Zhang K et al. Differential Risk Factors for Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage. Neurocrit Care. 2025 Aug. doi: 10.1007/s12028-025-02218-z. PMID: 39904873.


2. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282-e361.


3. Morotti A, Boulouis G, Dowlatshahi D, et al. Standards for Detecting, Interpreting, and Reporting Noncontrast Computed Tomography Markers of Intracerebral Hemorrhage Expansion. Ann Neurol. 2019;86(4):480-492.